You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gastroesophageal junction cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

Recruiting
  • Gastric Cancer
  • +10 more
  • Kyiv, Ukraine
    National Cancer Institute
Aug 31, 2023

2D and 3D Primary Cell Cultures From Gastric and

Not yet recruiting
  • Gastric and Gastroesophageal Junction Cancer
    • Berlin, Germany
      Department of Anesthesiology and Operative Intensive Care Medici
    Sep 13, 2022

    Gastric Cancer, Gastroesophageal-junction Cancer Trial (Tcrx T cell)

    Not yet recruiting
    • Gastric Cancer
    • Gastroesophageal-junction Cancer
    • Tcrx T cell
    • (no location specified)
    Jul 21, 2022

    Esophageal Adenocarcinoma Trial in Clermont-Ferrand (Adipose tissue biopsies)

    Not yet recruiting
    • Esophageal Adenocarcinoma
    • Adipose tissue biopsies
    • Clermont-Ferrand, France
      CHU de Clermont-Ferrand
    Jul 19, 2023

    Gastroesophageal Junction Adenocarcinoma, Stomach Tumors Trial in Barcelona (Avelumab addition to perioperative chemo in GC and

    Recruiting
    • Gastroesophageal Junction Adenocarcinoma
    • Stomach Neoplasms
    • Avelumab addition to perioperative chemotherapy in GC and GEJC
    • Barcelona, Spain
      Vall d'Hebron Institute of Oncology
    Oct 11, 2022

    Gastric Cancer, Gastroesophageal Junction Cancer Trial in Seoul (afatinib, paclitaxel)

    Completed
    • Gastric Cancer
    • Gastroesophageal Junction Cancer
    • Seoul, Korea, Republic of
      Severance Hospital, Yonsei University Health System, Yonsei Canc
    Jan 26, 2023

    Gastric Cancer, Gastroesophageal Junction Cancer Trial in Nanjing (MAX-40279)

    Recruiting
    • Gastric Cancer
    • Gastroesophageal Junction Cancer
    • Nanjing, Jingsu, China
      Nanjing Drum Tower Hospital of Nanjing University Medical School
    May 29, 2022

    Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

    Recruiting
    • Adenocarcinoma
    • +8 more
    • Radiotherapy targeted to the primary lesion
    • +7 more
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Nov 7, 2023

    Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) Trial in Tianjin (Serplulimab+Paclitaxel+Apatinib,

    Recruiting
    • Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Jul 5, 2023

    MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer Trial (S095029, Pembrolizumab 200 mg)

    Not yet recruiting
    • MSI-H/dMMR Gastroesophageal-junction Cancer
    • MSI-H/dMMR Gastric Cancer
    • (no location specified)
    Oct 30, 2023

    Gastric Cancer, Gastroesophageal-junction Cancer, Esophageal Cancer Trial (LB1908)

    Not yet recruiting
    • Gastric Cancer
    • +3 more
    • LB1908
    • (no location specified)
    Sep 9, 2022

    Patterns in HER2-Positive Locally Advanced or Metastatic Gastric

    Not yet recruiting
    • Gastric Cancer
      • (no location specified)
      Feb 1, 2023

      Gastric Cancer, Gastroesophageal-junction Cancer Trial (IBI315, Oxaliplatin, Capecitabine)

      Not yet recruiting
      • Gastric Cancer
      • Gastroesophageal-junction Cancer
      • (no location specified)
      Nov 2, 2022

      Gastric Cancer, Gastroesophageal-junction Cancer Trial in Wuhan, Nanjing, Taiyuan (Tislelizumab, S-1, Oxaliplatin)

      Not yet recruiting
      • Gastric Cancer
      • Gastroesophageal-junction Cancer
      • Wuhan, Hubei, China
      • +2 more
      Jan 16, 2023

      Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, Korea, Republic of, Taiwan (Bemarituzumab, CAPOX, SOX)

      Recruiting
      • Gastric Cancer
      • Gastroesophageal Junction Cancer
      • Northport, New York
      • +13 more
      Jan 4, 2023

      Locally Advanced Gastric Cancer, Metastatic HER2 Positive Gastroesophageal Junction Cancer Trial in Beijing, Changsha, Shanghai

      Recruiting
      • Locally Advanced Gastric Cancer
      • Metastatic HER2 Positive Gastroesophageal Junction Cancer
      • Beijing, Beijing, China
      • +2 more
      Feb 21, 2022

      Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Multiple Locations

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • +3 more
      • Routine care as per site standard
      • Multiple Locations, Germany
        Multiple sites, Gemany
      Jun 3, 2022

      Gastric Cancer, Gastroesophageal-junction Cancer Trial in Gyeonggi-do (Tepotinib plus paclitaxel)

      Recruiting
      • Gastric Cancer
      • Gastroesophageal-junction Cancer
      • Tepotinib plus paclitaxel
      • Gyeonggi-do, Korea, Republic of
        Hallym University Medical Center
      Jun 29, 2022

      Esophageal Cancer, Small Bowel Cancer, Gastroesophageal-junction Cancer Trial in Sacramento (Ablative local therapy)

      Recruiting
      • Esophageal Cancer
      • +10 more
      • Ablative local therapy
      • Sacramento, California
        University of California, Davis
      Oct 27, 2023

      Esophageal Adenocarcinoma, Esophageal Cancer, HER-2 Protein Overexpression Trial in New York, Providence (Nivolumab, Trastuzumab

      Not yet recruiting
      • Esophageal Adenocarcinoma
      • +3 more
      • New York, New York
      • +1 more
      Jul 28, 2022

      Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (XELOX combined with Fruquintinib and Sintilimab)

      Not yet recruiting
      • Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
      • XELOX combined with Fruquintinib and Sintilimab
      • (no location specified)
      Oct 17, 2023

      Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (PD-1 inhibitor)

      Recruiting
      • Gastric or Gastroesophageal Junction Adenocarcinoma
      • PD-1 inhibitor
      • Guangzhou, China
        Sun Yat-sen University Cancer Center
      Aug 9, 2023

      Gastric or Gastroesophageal Junction Cancer Trial in Beijing (SHR-1701?CAPOX/FOLFOX, Placebo?CAPOX/FOLFOX)

      Recruiting
      • Gastric or Gastroesophageal Junction Cancer
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Dec 14, 2021

      Nivolumab in Treatment of Early Stage Esophageal or

      Not yet recruiting
      • Esophageal Carcinoma
      • Gastroesophageal Junction Carcinoma
        • Louisville, Kentucky
        • +2 more
        Mar 21, 2023

        Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric

        Available
        • Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer
        • +3 more
        • Morristown, New Jersey
          AMG Hematology/Oncology
        Sep 15, 2023